AU2002362383A1 - Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies - Google Patents

Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies

Info

Publication number
AU2002362383A1
AU2002362383A1 AU2002362383A AU2002362383A AU2002362383A1 AU 2002362383 A1 AU2002362383 A1 AU 2002362383A1 AU 2002362383 A AU2002362383 A AU 2002362383A AU 2002362383 A AU2002362383 A AU 2002362383A AU 2002362383 A1 AU2002362383 A1 AU 2002362383A1
Authority
AU
Australia
Prior art keywords
peptides
post
treatment
translational modifications
autoimmune pathologies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002362383A
Other versions
AU2002362383B2 (en
Inventor
Jean-Paul Briand
Gilles Guichard
Jean-Gerard Guillet
Fanny Sylvie Michele Monneaux
Sylviane Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0112041A external-priority patent/FR2829768B1/en
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2002362383A1 publication Critical patent/AU2002362383A1/en
Application granted granted Critical
Publication of AU2002362383B2 publication Critical patent/AU2002362383B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002362383A 2001-09-18 2002-09-18 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies Expired AU2002362383B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/12041 2001-09-18
FR0112041A FR2829768B1 (en) 2001-09-18 2001-09-18 USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL TYPE MODIFICATIONS IN THE TREATMENT OF AUTOIMMUNE CONDITIONS
PCT/FR2002/003186 WO2003025014A2 (en) 2001-09-18 2002-09-18 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies

Publications (2)

Publication Number Publication Date
AU2002362383A1 true AU2002362383A1 (en) 2003-06-05
AU2002362383B2 AU2002362383B2 (en) 2008-10-09

Family

ID=8867384

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002362383A Expired AU2002362383B2 (en) 2001-09-18 2002-09-18 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies

Country Status (7)

Country Link
US (3) US7872098B1 (en)
EP (2) EP1427755A2 (en)
JP (1) JP4160505B2 (en)
AU (1) AU2002362383B2 (en)
CA (1) CA2460704A1 (en)
FR (1) FR2829768B1 (en)
WO (1) WO2003025014A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338773T3 (en) * 2001-09-06 2010-05-12 Centre National De La Recherche Scientifique (Cnrs) MODIFIED PEPTIDES AND ITS USE FOR THE TREATMENT OF AUTOIMMUNITY DISEASES.
FR2931360B1 (en) * 2008-05-20 2012-05-18 Centre Nat Rech Scient NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAME AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS
BR112014014492B1 (en) * 2011-12-13 2022-05-24 Centre National De La Recherche Scientifique Modified peptides or salts thereof, composition and pharmaceutical composition comprising said peptides, as well as use of the pharmaceutical composition to treat autoimmune diseases
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases
US20210308211A1 (en) * 2020-03-29 2021-10-07 Immupharma France Sa Method of treating viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338773T3 (en) * 2001-09-06 2010-05-12 Centre National De La Recherche Scientifique (Cnrs) MODIFIED PEPTIDES AND ITS USE FOR THE TREATMENT OF AUTOIMMUNITY DISEASES.

Similar Documents

Publication Publication Date Title
AU2003254950A1 (en) Peptides and drugs containing the same
HUP0103369A3 (en) Use of insulinotropic peptides
GB0218205D0 (en) Human ZZAP1 protein
AU2001259837A1 (en) Therapeutic pore-forming peptides
EP1462455A4 (en) Novel peptides and medicinal uses thereof
EP1414848A4 (en) Replikin peptides and uses thereof
EP1419175A4 (en) Replikin peptides and uses thereof
AU2003226899A8 (en) Human diabetes-mediating proteins
AU2002362383A1 (en) Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
AU2003272423A8 (en) Centrosome proteins and uses thereof
HK1209049A1 (en) Survivin-derived peptides and use thereof
AU2003293500A1 (en) Lactoferrin in the reduction of pain
GB0109438D0 (en) Peptides
AU2002318186A1 (en) Novel human kielin-like proteins and polynucleotides encoding the same
WO2002072611A8 (en) Novel human egf-family proteins and polynucleotides encoding the same
AU2002245593A1 (en) Novel human dectin proteins and polynucleotides encoding the same
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same
SG2012018057A (en) Replikin peptides and uses thereof
AU2002257630A1 (en) Human mrp5-like protein
AUPR589701A0 (en) Novel peptide and use thereof
GB0113705D0 (en) Therapeutic peptides
AU2002252296A1 (en) Novel human transporter proteins and polynucleotides encoding the same
AU2002328853A1 (en) Carcinoma-related peptides
AU2001241673A1 (en) Novel human regulatory protein and polynucleotides encoding the same
GB0222255D0 (en) Peptides and their use